Join
Live feed
·
INSIDERFilingvia Quantisnow
Galectin Therapeutics Inc. logo

Chief Medical Officer Jamil Khurram sold $88,888 worth of shares (16,250 units at $5.47), sold $573,622 worth of shares (104,867 units at $5.47), exercised 83,000 shares at a strike of $2.35 and exercised 16,250 shares at a strike of $1.23, decreasing direct ownership by 83% to 4,479 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GALT (Galectin Therapeutics Inc.) and more on Quantisnow.